Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
551 - We have a patient survey conducted by a patient association looking at reasons for stopping therapy. Can we use this information in an unbranded APS to highlight the most common reasons for stopping therapy?
-
For the use described in your question, the surveys would either need to be published in a peer reviewed journal, or it would need to be designed, conducted & analyzed without sponsor’s influence (s5.10.2). The messaging would be limited to aspects which are non-clinical (so as not to require a clinical trial as evidentiary support) and you’ll need to remove messaging deemed to be disparaging to a product or product class/category. CAVEAT: This is a very general answer to a general question. There are MANY factors which could impact whether a survey is acceptable as evidentiary support. In my experience, things have gone more smoothly when clients first submitted the survey (or at least a thorough description) in a written opinion request (see our fee schedule) along with the types of messages they wished to convey. Sometimes the issue is the reference, but often the issue is the underlying message.
